Peer Review History
| Original SubmissionNovember 27, 2023 |
|---|
|
PONE-D-23-38877Acaricidal activity of Egyptian crude plant extracts against Haemaphysalis longicornis ticksPLOS ONE Dear Dr. Nishikawa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 06 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Brian Stevenson, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: This study was supported by KAKENHI Grants from the Japan Society for the Promotion of Science (20F20402 [Y.N.]). Please provide an amended statement that declares all the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript on testing plant extracts against the Asian longhorned ticks is quite topical, and important. These extracts were further analyzed on LC-MS. Most of the m/s is straight forward with well written methods, and analysis. However, the reported data is from a non-replicated trial wherein each of the treatment (plant extracts at specific concentrations) were tested on five ticks that were released into a single Petri dish. That would constitute a single replicate. A few more suggestions: Mortality criterion can be more refined. Extraction methods are convincing, however drying them for extended period in open air, and again leaving the applied filter paper for 72 hrs (before testing) is problematic. Some of the compounds (such as camphor etc.,) will evaporate therefore skewing the natural composition of the extracts. Overall, a nice and much-needed study but unfortunately the above-mentioned shortcomings needed to be addressed for consideration. Reviewer #2: Major Comments 1. From my reading of the paper it appears that the screen was performed once from a single extraction of each compound. If true, I still think this study remains technically sound as a launching point for future studies given the substantial amount of work that appears to be required to undertake these experiments. However, I would gently request that, if possible, additional replicates be performed with Artemisia judaica extracts to confirm activity. If possible this experiment would be best with a new isolation from a new plant (fresh or dried). Minor Comments 1. Throughout Text: Change mg/ml to mg/mL 2. Line 50: Citation does not appear to support the claim made. Perhaps citation #3 was meant instead? 3. Line 66: Relevance of the sentence “In a previous study, an in vitro feeding assay system using fipronil and ivermectin was established [10]” is unclear 4. Line 72-73: “Consequently, there is a growing need to explore alternative acaricidal treatments from natural resources, such as plants” The arguments provided do not inherently require alternative treatments be from natural resources. If the authors think natural sources are necessary for a reason not made explicitly clear, they should make that argument. Alternatively, the sentence should be changed to be suggest that one source of alternative acaricidal treatments could be natural resources, such as plants. 5. Line 119: I appreciate that there is a substantial difference between healthy ticks and ticks only moving their appendages, but it’s difficult to justify classifying the latter as dead. If possible, can the data be split between living, moribund, and dead? Or only binary data are recorded, perhaps just using a word slightly less absolute than mortality? If changed, please apply throughout the paper. This is unlikely to change interpretation of the paper so I’ll leave this to author and editor discretion. 6. Line 214: The Solvent and the Total Number of Ticks for Each Plant Concentration are the same for every row, so the columns could be removed and that information added to the table legend. 7. Line 243: What is test is the p-value derived from? What’s the null hypothesis here? Please include in figure legend. 8. “The traditional medicinal uses of A. judaica are treating gastrointestinal disorders, cardiovascular problems, atherosclerosis, arthritis, and skin and eyesight disorders, along with immune system enhancement and anticancer effects [39,40].” Unclear to me whether invoking traditional medicine strengthens the author’s narrative, might suggest removing this sentence. 9. “In the current study, A. judaica showed strong time- and concentration-dependent activities against hard adult female ticks of H. longicornis, suggesting a novel medicinal use of this plant extract as an acaricidal therapeutic.” I would advise caution saying you’ve uncovered a novel “medicinal” role. I think the current study, which did not involve any vertebrate exposures, may go as far to suggest that compounds warrant further study or could be leveraged as an environmental treatment. 10. “Among them, camphor oil exhibited the highest base intensity (Figs. 2 and 3, Table 5), suggesting its potential role as the primary component responsible for the activity of the plant.” I suggest replacing “the primary” with “a” 11. “The mechanism by which the extract kills ticks may involve the concentration of camphor oil in the extract, which might suffocate the ticks inside the incubation Petri dish, leading to mortality that is concentration- and time-dependent (Figs. 1 and 2A, Tables 2 and 5).” I didn’t understand this statement—how would the oil suffocate the ticks? 12. “Therefore, this extract can effectively control hard ticks in exposed livestock.” I would recommend hedging this. “This extract could potentially control” ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Acaricidal activity of Egyptian crude plant extracts against Haemaphysalis longicornis ticks PONE-D-23-38877R1 Dear Dr. Nishikawa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Brian Stevenson, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-38877R1 PLOS ONE Dear Dr. Nishikawa, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Brian Stevenson Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .